Viscogliosi Brothers Acquisition Corp (Nasdaq: VBOC) is a blank-check company sponsored by Viscogliosi Brothers, LLC, a firm with a long track record in healthcare and medical technology investing. The SPAC completed its IPO in 2022, targeting acquisition opportunities in the healthcare sector with a focus on medical devices and orthopedic-adjacent businesses. On July 6, 2023, the company filed a DEFA14A with the SEC, submitting additional definitive proxy materials in connection with an ongoing shareholder solicitation. The DEFA14A supplement indicates the SPAC was actively engaged in a proxy process at the time of filing. Visit SpacDesk and sign up for full data, filings history, and deal tracking on VBOC and hundreds of other active SPACs.